Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saurabh Mukhopadhyay

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|September 1, 2018
Bayesian detection of potential risk using inference on blinded safety dataSaurabh Mukhopadhyay, Brian Waterhouse, Alan Hartford
Journal of Biopharmaceutical Statistics|December 12, 2022
Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowingEmmanouil Spanakis, Martina Kron, Mareike Bereswill, et al.
Contemporary Clinical Trials|July 19, 2023
Leveraging external evidence using Bayesian hierarchical model and propensity score in the presence of covariatesXiaotian Chen, Yi Yao, Li Wang, et al.
Journal of Biopharmaceutical Statistics|April 17, 2020
Modified Goldilocks Design with strict type I error control in confirmatory clinical trialsTianyu Zhan, Hongtao Zhang, Alan Hartford, et al.
Pharmaceutical Statistics|November 2, 2021
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluationBrian Waterhouse, Alan Hartford, Saurabh Mukhopadhyay, et al.
Pharmaceutical Statistics|December 10, 2025
Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and ImplementationsSaurabh Mukhopadhyay, Yujie Zhao, Xiaotian Chen, et al.
Therapeutic Innovation & Regulatory Science|January 24, 2024
Incorporating Prior Data in Quantitative Benefit-Risk Assessments: Case Study of a Bayesian MethodSai Dharmarajan, Zhong Yuan, Yeh-Fong Chen, et al.
Contemporary Clinical Trials|April 10, 2022
Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trialsHong Li, Kevin J Gleason, Yiran Hu, et al.
BMJ (Clinical Research Ed.)|June 22, 2002
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritisH Ralph Schumacher, Judith A Boice, David I Daikh, et al.
Blood|November 18, 2005
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathyChristos Tsoukas, M Elaine Eyster, Sumiko Shingo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|September 1, 2018
Bayesian detection of potential risk using inference on blinded safety dataSaurabh Mukhopadhyay, Brian Waterhouse, Alan Hartford
Journal of Biopharmaceutical Statistics|December 12, 2022
Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowingEmmanouil Spanakis, Martina Kron, Mareike Bereswill, et al.
Contemporary Clinical Trials|July 19, 2023
Leveraging external evidence using Bayesian hierarchical model and propensity score in the presence of covariatesXiaotian Chen, Yi Yao, Li Wang, et al.
Journal of Biopharmaceutical Statistics|April 17, 2020
Modified Goldilocks Design with strict type I error control in confirmatory clinical trialsTianyu Zhan, Hongtao Zhang, Alan Hartford, et al.
Pharmaceutical Statistics|November 2, 2021
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluationBrian Waterhouse, Alan Hartford, Saurabh Mukhopadhyay, et al.
Pharmaceutical Statistics|December 10, 2025
Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and ImplementationsSaurabh Mukhopadhyay, Yujie Zhao, Xiaotian Chen, et al.
Therapeutic Innovation & Regulatory Science|January 24, 2024
Incorporating Prior Data in Quantitative Benefit-Risk Assessments: Case Study of a Bayesian MethodSai Dharmarajan, Zhong Yuan, Yeh-Fong Chen, et al.
Contemporary Clinical Trials|April 10, 2022
Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trialsHong Li, Kevin J Gleason, Yiran Hu, et al.
BMJ (Clinical Research Ed.)|June 22, 2002
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritisH Ralph Schumacher, Judith A Boice, David I Daikh, et al.
Blood|November 18, 2005
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathyChristos Tsoukas, M Elaine Eyster, Sumiko Shingo, et al.
Pageof 2